State Pharma has signed a distributorship agreement with Pakistan-based Hiranis Pharmaceuticals Private Limited, expanding its international supplier network as part of efforts to maintain a reliable supply of medicines across the Maldives.
The agreement is intended to establish a stronger procurement channel for pharmaceutical products and reduce the risk of disruptions in the availability of essential medicines.
State Pharma said the partnership forms part of its broader strategy to diversify and strengthen relationships with pharmaceutical manufacturers overseas, with particular emphasis on maintaining consistent access to safe and high-quality medicines.
Under the arrangement, State Pharma will work with Hiranis Pharmaceuticals to facilitate the distribution of its pharmaceutical products in the Maldives.
The company said strengthening direct and dependable supply channels is important to ensuring medicines remain accessible to communities throughout the country, including residents living outside the Greater Malé region.
Ensuring continuity of pharmaceutical supplies can be particularly challenging in the Maldives due to the country’s dispersed geography and heavy dependence on imported medicines. Products brought into the country must subsequently be distributed across numerous islands, making reliable procurement, logistics and inventory management important to maintaining availability.
State Pharma said the new agreement is expected to support efforts to create a more sustainable pharmaceutical supply chain and facilitate smoother access to essential medicines.
Hiranis Pharmaceuticals is a pharmaceutical manufacturer based in Pakistan with experience supplying products to international markets. Its products have been distributed in several Asian markets, including the Maldives, the Philippines and Afghanistan.
The partnership adds Hiranis Pharmaceuticals to State Pharma’s expanding network of international suppliers as the company works to diversify the sources from which medicines are procured.
Strengthening pharmaceutical security has received increased attention in the Maldives in recent years, particularly following global supply chain disruptions that demonstrated the vulnerability of import-dependent countries to shortages and delays.
For the Maldives, where most pharmaceutical products are sourced from overseas, diversifying suppliers can help reduce reliance on individual procurement channels and provide greater flexibility when disruptions occur in particular markets.
State Pharma said its latest agreement is aimed at supporting the wider pharmaceutical sector while ensuring patients have dependable access to medicines.
The company described the partnership as another step towards establishing a resilient supply system capable of delivering quality pharmaceutical products continuously across the country.
